News By Tag Industry News News By Location Country(s) Industry News
| ![]() Global Contraceptives Market to Expand, Spurred by Rising Incidences of Unwanted PregnanciesMost unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes and hepatitis B.
By: Fact.MR Propelled by these abovementioned factors, the global contraceptives market is set to expand positively during the forecast period (2020-2025). The global contraceptives market is projected to reach a value of US$ 37,242.7 by 2025-end, expanding at a CAGR of 6.4%. Other developments such as introduction of innovative devices is also expected to boost market growth for contraceptives. Mandatory social distancing amid the COVID-19 pandemic, however, is anticipated to generate tremors in the global contraceptives market supply chain, owing to limited production capacity due to less employee strength and avoidance of physical contact among adults. Read Report- https://www.factmr.com/ Key Takeaways of Global Contraceptives Market Study • Contraceptive devices shall capture the maximum market share of the global contraceptives market (>50%). This is attributed to the major side effects of ingesting contraceptive drugs, such as nausea, headache, weight gain, increased bleeding, dysmenorrhea and menstrual changes, among women. The introduction of custom-fit condoms by key market players is equally expected to boost market share. Anticipated CAGR for the forecast period is pegged at 6.6%. • Hospitals shall account for the maximum distribution of contraceptive devices among patients. Favorable reimbursement policies to hospitals is a key driver behind the growth of this segment. Projections indicate a market share of one-third during the forecast period. • North America shall dominate the global contraceptives market, due to increased incidences of unwanted pregnancies and burgeoning demand for reversible contraceptives among the patients. The region is expected to surpass a valuation of US$ 12.9 Bn growing at a CAGR of 6.6% during the forecast period. • Asia-Pacific shows high potential for growth of the global contraceptives market. The region shows staggering prospects, with a CAGR pegged at 6.8% throughout the forecast period. • The COVID-19 pandemic is anticipated to initiate a decline in the sales of contraceptives globally. This is attributed to social distancing among young adults in order to contain the spread of the virus. • Supply-chain disruptions are anticipated, attributed to limited production capacity of manufacturing plants. Condoms, the most popular contraceptive, are anticipated to register significant downturn in production. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||